Hepatitis News : Hep C Takes 15 Years Off Life Span, Raises Death Risk 12-Fold
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hep Newsletter
Join Us:

Back to home » Hepatitis News » October 2013


October 21, 2013

Hep C Takes 15 Years Off Life Span, Raises Death Risk 12-Fold

People with hepatitis C virus (HCV) die 15 years earlier and have a 12-times greater risk of death when compared with those without the virus, the National AIDS Treatment Advocacy Project (NATAP) reports.  The Centers for Disease Control and Prevention (CDC) conducted a multicohort analysis, examining electronic medical records of adults who received treatment at least once between 2006 and 2010 in four health care systems. The researchers then compared the findings of their so-called Chronic Hepatitis Cohort Study (CHeCS) with the national Multiple Cause of Death (MCOD) study covering the same period of time. They presented their findings at the IDWeek 2013 conference in San Francisco.

Looking at the records of 11,703 people with hep C, who made up a half of a percent of the 2.1 million people in the CHeCS cohort, the investigators found that 1,590 (14 percent) died during the study period. Sixty percent were between 45 and 59 years old, and 34 percent were 60 and older. When compared with the MCOD group, those in CHeCS had a 12-times greater mortality rate. With an average age at death of 59, those in the CHeCS group died an average of 15 years earlier than the typical American.

Hep C, the researchers found, is vastly unreported as a cause of death, registered in only 19 percent of death certificates among those in the cohort who died. Based on this finding, the investigators extrapolated that more than 80,000 Americans who died in 2010 had hep C. They also projected that 53,000 people died as a consequence of hep C in 2010.  

To read the NATAP report, click here.

Search: Hepatitis C virus, HCV, hep C, NATAP, National AIDS Treatment Advocacy Project, Centers for Disease Control and Prevention, CDC, Chronic Hepatitis Cohort Study, CHeCS, Multiple Cause of Death, MCOD, mortality risk, life span.

Scroll down to comment on this story. Click here to visit the Hep Forums and ask questions about this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The Hep team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (2 total)

[Go to top]

Quick Links
Current Issue
Hep TV
Services Directory
Conference News
Top Stories
Treatment News
Hep Exclusives
All About Hepatitis
• Hepatitis A
• Hepatitis B
• Hepatitis C
HCV/HIV Coinfection
Help Paying For Meds
Clinical Trials
Tell us what you think
Should Medicaid limit access to new hep C drugs?

Hepatitis C Reader Survey
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.